Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kline

Showing results (151-160 of 189) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|February 4, 2021
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's WitnessesPeter A Riedell, Meng Wu, Jennifer M Collins, et al.
American Journal of Physiology. Cell Physiology|August 13, 2010
Effect of Ca2+ binding properties of troponin C on rate of skeletal muscle force redevelopmentRyan S Lee, Svetlana B Tikunova, Kristopher P Kline, et al.
Journal of Medicinal Chemistry|October 16, 1992
Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptidesC E Peishoff, F E Ali, J W Bean, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculatureRobbert M Spaapen, Michael Y K Leung, Mercedes B Fuertes, et al.
Cancer|February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Annals of Translational Medicine|June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in <i>FLT3</i>-mutated acute myeloid leukemia (AML) patientsGong He, Erika Belmont, Theodore Karrison, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 21, 2006
Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1Yuning Xiong, Kathleen A Donovan, Michael P Kline, et al.
Signal Transduction and Targeted Therapy|April 26, 2026
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changesNada S Aboelella, Ryan Park, Erting Tang, et al.
Matter|December 13, 2021
Antigen-Multimers: Specific, Sensitive, Precise, and Multifunctional High-Avidity CAR-Staining ReagentsYifei Hu, Guoshuai Cao, Xiufen Chen, et al.
Oncoimmunology|March 24, 2021
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patientsJana Rakova, Iva Truxova, Peter Holicek, et al.
Pageof 19

Showing results (151-160 of 189) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|February 4, 2021
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's WitnessesPeter A Riedell, Meng Wu, Jennifer M Collins, et al.
American Journal of Physiology. Cell Physiology|August 13, 2010
Effect of Ca2+ binding properties of troponin C on rate of skeletal muscle force redevelopmentRyan S Lee, Svetlana B Tikunova, Kristopher P Kline, et al.
Journal of Medicinal Chemistry|October 16, 1992
Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptidesC E Peishoff, F E Ali, J W Bean, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Therapeutic activity of high-dose intratumoral IFN-β requires direct effect on the tumor vasculatureRobbert M Spaapen, Michael Y K Leung, Mercedes B Fuertes, et al.
Cancer|February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Annals of Translational Medicine|June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in <i>FLT3</i>-mutated acute myeloid leukemia (AML) patientsGong He, Erika Belmont, Theodore Karrison, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 21, 2006
Identification of two groups of smoldering multiple myeloma patients who are either high or low producers of interleukin-1Yuning Xiong, Kathleen A Donovan, Michael P Kline, et al.
Signal Transduction and Targeted Therapy|April 26, 2026
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changesNada S Aboelella, Ryan Park, Erting Tang, et al.
Matter|December 13, 2021
Antigen-Multimers: Specific, Sensitive, Precise, and Multifunctional High-Avidity CAR-Staining ReagentsYifei Hu, Guoshuai Cao, Xiufen Chen, et al.
Oncoimmunology|March 24, 2021
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patientsJana Rakova, Iva Truxova, Peter Holicek, et al.
Pageof 19